Your browser doesn't support javascript.
Influenza Virus and SARS-CoV-2 Vaccines.
Sandor, Adam M; Sturdivant, Michael S; Ting, Jenny P Y.
  • Sandor AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Sturdivant MS; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Ting JPY; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
J Immunol ; 206(11): 2509-2520, 2021 06 01.
Article in English | MEDLINE | ID: covidwho-1239056
ABSTRACT
Seasonal influenza and the current COVID-19 pandemic represent looming global health challenges. Efficacious and safe vaccines remain the frontline tools for mitigating both influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced diseases. This review will discuss the existing strategies for influenza vaccines and how these strategies have informed SARS-CoV-2 vaccines. It will also discuss new vaccine platforms and potential challenges for both viruses.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza A virus / Influenza Vaccines / Influenza, Human / Pandemics / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: J Immunol Year: 2021 Document Type: Article Affiliation country: Jimmunol.2001287

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza A virus / Influenza Vaccines / Influenza, Human / Pandemics / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: J Immunol Year: 2021 Document Type: Article Affiliation country: Jimmunol.2001287